Literature DB >> 21279603

MR spectroscopy and spectroscopic imaging of the brain.

He Zhu1, Peter B Barker.   

Abstract

Magnetic resonance spectroscopy (MRS) and the related technique of magnetic resonance spectroscopic imaging (MRSI) are widely used in both clinical and preclinical research for the non-invasive evaluation of brain metabolism. They are also used in medical practice, although their ultimate clinical value continues to be a source of discussion. This chapter reviews the general information content of brain spectra and commonly used protocols for both MRS and MRSI and also touches on data analysis methods and quantitation. The main focus is on proton MRS for application in humans, but many of the methods are also applicable to other nuclei and studies of animal models as well.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21279603      PMCID: PMC3416028          DOI: 10.1007/978-1-61737-992-5_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  100 in total

1.  Application of time-domain fitting in the quantification of in vivo 1H spectroscopic imaging data sets.

Authors:  R de Beer; A van den Boogaart; D van Ormondt; W W Pijnappel; J A den Hollander; A J Marien; P R Luyten
Journal:  NMR Biomed       Date:  1992 Jul-Aug       Impact factor: 4.044

2.  Fast proton spectroscopic imaging of human brain using multiple spin-echoes.

Authors:  J H Duyn; C T Moonen
Journal:  Magn Reson Med       Date:  1993-10       Impact factor: 4.668

3.  Detection of myelin breakdown products by proton magnetic resonance spectroscopy.

Authors:  C A Davie; C P Hawkins; G J Barker; A Brennan; P S Tofts; D H Miller; W I McDonald
Journal:  Lancet       Date:  1993-03-06       Impact factor: 79.321

4.  Lipid-suppressed single- and multisection proton spectroscopic imaging of the human brain.

Authors:  D M Spielman; J M Pauly; A Macovski; G H Glover; D R Enzmann
Journal:  J Magn Reson Imaging       Date:  1992 May-Jun       Impact factor: 4.813

5.  The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio.

Authors:  R E Brenner; P M Munro; S C Williams; J D Bell; G J Barker; C P Hawkins; D N Landon; W I McDonald
Journal:  Magn Reson Med       Date:  1993-06       Impact factor: 4.668

6.  Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies.

Authors:  P M Mathews; F Andermann; K Silver; G Karpati; D L Arnold
Journal:  Neurology       Date:  1993-12       Impact factor: 9.910

7.  Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types.

Authors:  J Urenjak; S R Williams; D G Gadian; M Noble
Journal:  J Neurosci       Date:  1993-03       Impact factor: 6.167

8.  Multisection proton MR spectroscopic imaging of the brain.

Authors:  J H Duyn; J Gillen; G Sobering; P C van Zijl; C T Moonen
Journal:  Radiology       Date:  1993-07       Impact factor: 11.105

9.  Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.

Authors:  D L Rothman; O A Petroff; K L Behar; R H Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

10.  Alterations of brain metabolites in metachromatic leukodystrophy as detected by localized proton magnetic resonance spectroscopy in vivo.

Authors:  B Kruse; F Hanefeld; H J Christen; H Bruhn; T Michaelis; W Hänicke; J Frahm
Journal:  J Neurol       Date:  1993-12       Impact factor: 4.849

View more
  58 in total

Review 1.  Molecular brain imaging in the multimodality era.

Authors:  Julie C Price
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-21       Impact factor: 6.200

Review 2.  Preclinical imaging: an essential ally in modern biosciences.

Authors:  Lídia Cunha; Ildiko Horvath; Sara Ferreira; Joana Lemos; Pedro Costa; Domingos Vieira; Dániel S Veres; Krisztián Szigeti; Teresa Summavielle; Domokos Máthé; Luís F Metello
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

3.  A semiadiabatic spectral-spatial spectroscopic imaging (SASSI) sequence for improved high-field MR spectroscopic imaging.

Authors:  Rebecca E Feldman; Priti Balchandani
Journal:  Magn Reson Med       Date:  2015-10-31       Impact factor: 4.668

Review 4.  Various MRS application tools for Alzheimer disease and mild cognitive impairment.

Authors:  F Gao; P B Barker
Journal:  AJNR Am J Neuroradiol       Date:  2014-04-17       Impact factor: 3.825

5.  Whole brain neuronal abnormalities in focal epilepsy quantified with proton MR spectroscopy.

Authors:  Ivan I Kirov; Ruben Kuzniecky; Hoby P Hetherington; Brian J Soher; Matthew S Davitz; James S Babb; Heath R Pardoe; Jullie W Pan; Oded Gonen
Journal:  Epilepsy Res       Date:  2017-12-02       Impact factor: 3.045

6.  Edited magnetic resonance spectroscopy detects an age-related decline in brain GABA levels.

Authors:  Fei Gao; Richard A E Edden; Muwei Li; Nicolaas A J Puts; Guangbin Wang; Cheng Liu; Bin Zhao; Huiquan Wang; Xue Bai; Chen Zhao; Xin Wang; Peter B Barker
Journal:  Neuroimage       Date:  2013-04-13       Impact factor: 6.556

7.  A quantitative meta-analysis of brain glutamate metabolites in aging.

Authors:  David R Roalf; Valerie J Sydnor; Madison Woods; David A Wolk; J Cobb Scott; Ravinder Reddy; Paul J Moberg
Journal:  Neurobiol Aging       Date:  2020-07-21       Impact factor: 4.673

8.  Parallel reconstruction in accelerated multivoxel MR spectroscopy.

Authors:  V O Boer; D W J Klomp; J Laterra; P B Barker
Journal:  Magn Reson Med       Date:  2015-06-17       Impact factor: 4.668

9.  Metabolic Abnormalities in the Hippocampus of Patients with Schizophrenia: A 3D Multivoxel MR Spectroscopic Imaging Study at 3T.

Authors:  E J Meyer; I I Kirov; A Tal; M S Davitz; J S Babb; M Lazar; D Malaspina; O Gonen
Journal:  AJNR Am J Neuroradiol       Date:  2016-07-21       Impact factor: 3.825

Review 10.  Chemistry and biochemistry of 13C hyperpolarized magnetic resonance using dynamic nuclear polarization.

Authors:  Kayvan R Keshari; David M Wilson
Journal:  Chem Soc Rev       Date:  2013-12-20       Impact factor: 54.564

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.